EcoDrugPlus

Ensembl ID : ENSCLMG00005010036
Gene Symbol: RPS4X
1 Cross references
497 Possible Orthologues:

Ensembl ID : ENSCLMG00005013723
Gene Symbol: PDGFRA
1 Cross references
204 Possible Orthologues:

Ensembl ID : ENSCLMG00005006556
Gene Symbol: -
Cross references: -
250 Possible Orthologues:

Ensembl ID : ENSCLMG00005006536
Gene Symbol: -
Cross references: -
192 Possible Orthologues:

Ensembl ID : ENSCLMG00005002786
Gene Symbol: RPL24
1 Cross references
318 Possible Orthologues:

Ensembl ID : ENSCLMG00005010064
Gene Symbol: -
Cross references: -
225 Possible Orthologues:

Ensembl ID : ENSCLMG00005016357
Gene Symbol: -
Cross references: -
211 Possible Orthologues:

Ensembl ID : ENSCLMG00005010603
Gene Symbol: -
Cross references: -
203 Possible Orthologues:

Ensembl ID : ENSCLMG00005010884
Gene Symbol: -
Cross references: -
189 Possible Orthologues:

Ensembl ID : ENSCLMG00005002586
Gene Symbol: -
Cross references: -
193 Possible Orthologues:

Ensembl ID : ENSCLMG00005002375
Gene Symbol: RPS15A
1 Cross references
566 Possible Orthologues:

Ensembl ID : ENSCLMG00005011285
Gene Symbol: -
Cross references: -
192 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).